Nonclassical antagonism between human lysozyme and AMPs against Pseudomonas aeruginosa.

FEBS Open Bio · 2021 · PMC7931236 · PMID 33480189

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a weak trendno p-value reported

aeruginosa lung infection, Tet009 and hLYS combination therapy manifested a weak trend toward reduced efficacy compared to hLYS monotherapy [ 37 ].

also in 1,404 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.